Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls—a pilot study

5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder

(2015) Pedro E Martinez et al.   NEUROPSYCHOPHARMACOLOGY

Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: A systematic review

(2014) Simone Toffoletto et al.   PSYCHONEUROENDOCRINOLOGY

Allopregnanolone and mood disorders

(2013) T. Bäckström et al.   PROGRESS IN NEUROBIOLOGY

Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus

(2011) Patrick Michael Shaughn O’Brien et al.   Archives of Womens Mental Health

Gonadal hormone regulation of the emotion circuitry in humans

(2011) G.A. van Wingen et al.   NEUROSCIENCE

Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons

(2011) T. Bäckström et al.   NEUROSCIENCE

Neuroimaging Evidence of Cerebellar Involvement in Premenstrual Dysphoric Disorder

(2010) Andrea J. Rapkin et al.   BIOLOGICAL PSYCHIATRY

Tolerance to allopregnanolone with focus on the GABA-A receptor

(2010) Sahruh Turkmen et al.   BRITISH JOURNAL OF PHARMACOLOGY

Regulation of GABAA Receptor Subunit Expression by Pharmacological Agents

(2010) M. Uusi-Oukari et al.   PHARMACOLOGICAL REVIEWS

Changes in functioning of mesolimbic incentive processing circuits during the premenstrual phase

(2010) Lindsey Ossewaarde et al.   Social Cognitive and Affective Neuroscience

Toward a functional neuroanatomy of premenstrual dysphoric disorder

(2007) Xenia Protopopescu et al.   JOURNAL OF AFFECTIVE DISORDERS